|
PSMA3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.879600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.149000E-01 |
| Normal-vs-Stage2 |
2.326800E-01 |
| Normal-vs-Stage3 |
2.628400E-01 |
| Normal-vs-Stage4 |
7.344400E-01 |
| Stage1-vs-Stage2 |
5.288800E-01 |
| Stage1-vs-Stage3 |
6.874600E-01 |
| Stage1-vs-Stage4 |
2.272800E-01 |
| Stage2-vs-Stage3 |
8.227800E-01 |
| Stage2-vs-Stage4 |
1.902170E-01 |
| Stage3-vs-Stage4 |
2.186800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.833400E-01 |
| Normal-vs-AfricanAmerican |
6.999600E-01 |
| Normal-vs-Asian |
3.843000E-01 |
| Caucasian-vs-AfricanAmerican |
6.799000E-01 |
| Caucasian-vs-Asian |
7.431800E-01 |
| AfricanAmerican-vs-Asian |
5.791000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.562630E-01 |
| Normal-vs-Female |
8.449200E-01 |
| Male-vs-Female |
2.013800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.542000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.564400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.628400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.924400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.050000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.598600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.020400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.078400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.734600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.546200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.965200E-01 |
| Normal-vs-Grade 2 |
9.942600E-01 |
| Normal-vs-Grade 3 |
6.321500E-02 |
| Normal-vs-Grade 4 |
3.535400E-01 |
| Grade 1-vs-Grade 2 |
7.014600E-01 |
| Grade 1-vs-Grade 3 |
2.575400E-01 |
| Grade 1-vs-Grade 4 |
4.308000E-01 |
| Grade 2-vs-Grade 3 |
4.163500E-02 |
| Grade 2-vs-Grade 4 |
3.085600E-01 |
| Grade 3-vs-Grade 4 |
6.872000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.539600E-01 |
| Normal-vs-ccB subtype |
1.875920E-02 |
| ccA subtype-vs-ccB subtype |
1.370380E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.781200E-01 |
| Normal-vs-N1 |
1.625880E-02 |
| N0-vs-N1 |
1.725590E-01 |
|
|
